Literature DB >> 31270656

Irreversible electroporation for catheter-based cardiac ablation: a systematic review of the preclinical experience.

Alan Sugrue1, Vaibhav Vaidya1, Chance Witt1, Christopher V DeSimone1, Omar Yasin1, Elad Maor2, Ammar M Killu1, Suraj Kapa1, Christopher J McLeod1, Damijan Miklavčič3, Samuel J Asirvatham4.   

Abstract

INTRODUCTION: Irreversible electroporation (IRE) utilizing high voltage pulses is an emerging strategy for catheter-based cardiac ablation with considerable growth in the preclinical arena.
METHODS: A systematic search for articles was performed from three sources (PubMed, EMBASE, and Google Scholar). The primary outcome was the efficacy of tissue ablation with characteristics of lesion formation evaluated by histologic analysis. The secondary outcome was focused on safety and damage to collateral structures.
RESULTS: Sixteen studies met inclusion criteria. IRE was most commonly applied to the ventricular myocardium (n = 7/16, 44%) by a LifePak 9 Defibrillator (n = 9/16, 56%), NanoKnife Generator (n = 2/16, 13%), or other custom generators (n = 5/16, 31%). There was significant heterogeneity regarding electroporation protocols. On histological analysis, IRE was successful in creating ablation lesions with variable transmurality depending on the electric pulse parameters and catheter used.
CONCLUSION: Preclinical studies suggest that cardiac tissue ablation using IRE shows promise in delivering efficacious, safe lesions.

Entities:  

Keywords:  Arrhythmias; Atrial fibrillation; Cardiac ablation; Catheter ablation; Irreversible electroporation; Pulsed electric field; Translational studies

Year:  2019        PMID: 31270656     DOI: 10.1007/s10840-019-00574-3

Source DB:  PubMed          Journal:  J Interv Card Electrophysiol        ISSN: 1383-875X            Impact factor:   1.900


  10 in total

1.  EView: An electric field visualization web platform for electroporation-based therapies.

Authors:  Enric Perera-Bel; Carlos Yagüe; Borja Mercadal; Mario Ceresa; Natalie Beitel-White; Rafael V Davalos; Miguel A González Ballester; Antoni Ivorra
Journal:  Comput Methods Programs Biomed       Date:  2020-08-02       Impact factor: 5.428

2.  Muscle contractions and pain sensation accompanying high-frequency electroporation pulses.

Authors:  Aleksandra Cvetkoska; Alenka Maček-Lebar; Peter Trdina; Damijan Miklavčič; Matej Reberšek
Journal:  Sci Rep       Date:  2022-05-16       Impact factor: 4.996

3.  AC Pulsed Field Ablation Is Feasible and Safe in Atrial and Ventricular Settings: A Proof-of-Concept Chronic Animal Study.

Authors:  Guido Caluori; Eva Odehnalova; Tomasz Jadczyk; Martin Pesl; Iveta Pavlova; Lucia Valikova; Steffen Holzinger; Veronika Novotna; Vladimir Rotrekl; Ales Hampl; Michal Crha; Dalibor Cervinka; Zdenek Starek
Journal:  Front Bioeng Biotechnol       Date:  2020-12-03

4.  Safety and chronic lesion characterization of pulsed field ablation in a Porcine model.

Authors:  Mark T Stewart; David E Haines; Damijan Miklavčič; Bor Kos; Nicole Kirchhof; Noah Barka; Lars Mattison; Matt Martien; Birce Onal; Brian Howard; Atul Verma
Journal:  J Cardiovasc Electrophysiol       Date:  2021-03-10

5.  First-in-Human Experience and Acute Procedural Outcomes Using a Novel Pulsed Field Ablation System: The PULSED AF Pilot Trial.

Authors:  Atul Verma; Lucas Boersma; David E Haines; Andrea Natale; Francis E Marchlinski; Prashanthan Sanders; Hugh Calkins; Douglas L Packer; John Hummel; Birce Onal; Sofi Rosen; Karl-Heinz Kuck; Gerhard Hindricks; Bradley Wilsmore
Journal:  Circ Arrhythm Electrophysiol       Date:  2021-12-29

6.  Preclinical Study of Biphasic Asymmetric Pulsed Field Ablation.

Authors:  Shengyu Bi; Fenglin Jia; Chang Lv; Qiang He; Xinyu Xu; Zhixiao Xue; Siying Su
Journal:  Front Cardiovasc Med       Date:  2022-03-24

Review 7.  Pulsed Field Ablation to Treat Atrial Fibrillation: A Review of the Literature.

Authors:  Antonio Di Monaco; Nicola Vitulano; Federica Troisi; Federico Quadrini; Imma Romanazzi; Valeria Calvi; Massimo Grimaldi
Journal:  J Cardiovasc Dev Dis       Date:  2022-03-24

8.  Epicardial Targets With Endocardial Ablation: Risks for the Unseen.

Authors:  Samuel J Asirvatham; Martin van Zyl; Fatima Ali-Ahmed
Journal:  JACC Case Rep       Date:  2022-09-21

Review 9.  The Defibrillation Conundrum: New Insights into the Mechanisms of Shock-Related Myocardial Injury Sustained from a Life-Saving Therapy.

Authors:  Nicolas Clementy; Alexandre Bodin; Arnaud Bisson; Ana-Paula Teixeira-Gomes; Sebastien Roger; Denis Angoulvant; Valérie Labas; Dominique Babuty
Journal:  Int J Mol Sci       Date:  2021-05-08       Impact factor: 5.923

10.  Reduction in Pulmonary Vein Stenosis and Collateral Damage With Pulsed Field Ablation Compared With Radiofrequency Ablation in a Canine Model.

Authors:  Brian Howard; David E Haines; Atul Verma; Douglas Packer; Nicole Kirchhof; Noah Barka; Birce Onal; Steve Fraasch; Damijan Miklavčič; Mark T Stewart
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-07-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.